Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Brazília
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleEffectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
- Where
- Curitiba, Minas Gerais, Salvador, São Paulo
- Életkor
- 0 év to 100 év
- People
- 200
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05541341 - 3. fázisTaking peopleA Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Where
- Cascavel, Curitiba, Florianópolis, Natal, Ribeirão Preto, São Carlos, São Paulo, SJRP
- Életkor
- 18 év and over
- People
- 1046 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06717347 · EU 2024-515566-13-00 - 3. fázisTaking peopleA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Where
- Barretos, Belo Horizonte, Bento Gonçalves, Brasília, Cascavel, Curitiba, Jaú, Joinville, Lages, Natal, Porto Alegre, Rio de Janeiro, Salvador, São Paulo
- Életkor
- 18 év and over
- People
- 904 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091865 · EU 2022-502785-25-00 - 2/3. fázisTaking peopleA Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Where
- Curitiba, Natal, São Paulo
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05139017 · EU 2022-502646-27-00 - 2. fázisTaking peopleStudy of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
- Where
- Barretos, Belo Horizonte, Brasília, Campinas, Curitiba, Florianópolis, Goiânia, Natal, Porto Alegre, Recife, Ribeirão Preto, Rio de Janeiro, São José do Rio Preto, São Luís, São Paulo, Sorocaba
- Életkor
- 65 év to 99 év
- People
- 80 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05952024 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Barretos, Curitiba, Porto Alegre, São José do Rio Preto
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - No phaseNot yet taking people in BrazíliaA Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma
- Where
- Campinas, Curitiba, São Paulo
- Életkor
- 18 év and over
- People
- 532
- Run by
- AstraZeneca
See details and how to joinNCT07882576 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Brasília, Curitiba, Porto Alegre, São Paulo
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00